Systemic Bacillus Calmette-Guérin (BCG) Infection in a Patient With Non-Muscle-Invasive Bladder Cancer: A Case Report

非肌层浸润性膀胱癌患者发生全身性卡介苗(BCG)感染:病例报告

阅读:2

Abstract

Intravesical Bacillus Calmette-Guérin (BCG) instillation is a widely used adjuvant therapy for non-muscle-invasive bladder cancer (NMIBC), typically associated with a favorable safety profile. However, severe complications such as systemic BCG infection, though rare, can occur and are potentially life-threatening. Diagnosing systemic BCG infection is challenging due to frequently negative microbiological results. We report the case of a 67-year-old immunocompetent man who developed a systemic BCG infection after undergoing BCG therapy for NMIBC. Initially misdiagnosed as a urinary tract infection, his condition worsened despite antibiotic treatment. The diagnosis of BCG sepsis was suspected after prolonged fever, asthenia, and other systemic symptoms. Prompt initiation of antituberculosis treatment with rifampicin, ethambutol, and isoniazid led to a full recovery. This case underscores the critical importance of early recognition and treatment of systemic BCG infections, particularly in patients presenting with persistent fever and no clear source of infection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。